Kyverna Therapeutics (KYTX) Competitors

Kyverna Therapeutics logo
$3.03 -0.01 (-0.33%)
Closing price 02/14/2025 04:00 PM Eastern
Extended Trading
$3.03 0.00 (0.00%)
As of 02/14/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

KYTX vs. TECX, AUTL, TKNO, SNDL, TRDA, KMDA, MLYS, RNAC, ALT, and MREO

Should you be buying Kyverna Therapeutics stock or one of its competitors? The main competitors of Kyverna Therapeutics include Tectonic Therapeutic (TECX), Autolus Therapeutics (AUTL), Alpha Teknova (TKNO), SNDL (SNDL), Entrada Therapeutics (TRDA), Kamada (KMDA), Mineralys Therapeutics (MLYS), Cartesian Therapeutics (RNAC), Altimmune (ALT), and Mereo BioPharma Group (MREO). These companies are all part of the "pharmaceutical products" industry.

Kyverna Therapeutics vs.

Kyverna Therapeutics (NASDAQ:KYTX) and Tectonic Therapeutic (NASDAQ:TECX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, community ranking, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk.

Kyverna Therapeutics received 2 more outperform votes than Tectonic Therapeutic when rated by MarketBeat users. However, 100.00% of users gave Tectonic Therapeutic an outperform vote while only 66.67% of users gave Kyverna Therapeutics an outperform vote.

CompanyUnderperformOutperform
Kyverna TherapeuticsOutperform Votes
10
66.67%
Underperform Votes
5
33.33%
Tectonic TherapeuticOutperform Votes
8
100.00%
Underperform Votes
No Votes

Kyverna Therapeutics presently has a consensus price target of $25.71, indicating a potential upside of 748.66%. Tectonic Therapeutic has a consensus price target of $80.50, indicating a potential upside of 126.31%. Given Kyverna Therapeutics' higher possible upside, analysts plainly believe Kyverna Therapeutics is more favorable than Tectonic Therapeutic.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kyverna Therapeutics
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.00
Tectonic Therapeutic
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17

18.1% of Kyverna Therapeutics shares are owned by institutional investors. Comparatively, 62.6% of Tectonic Therapeutic shares are owned by institutional investors. 9.2% of Tectonic Therapeutic shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Tectonic Therapeutic had 1 more articles in the media than Kyverna Therapeutics. MarketBeat recorded 6 mentions for Tectonic Therapeutic and 5 mentions for Kyverna Therapeutics. Kyverna Therapeutics' average media sentiment score of 0.77 beat Tectonic Therapeutic's score of 0.70 indicating that Kyverna Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kyverna Therapeutics
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Tectonic Therapeutic
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tectonic Therapeutic has lower revenue, but higher earnings than Kyverna Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kyverna Therapeutics$7.03M18.61-$60.37MN/AN/A
Tectonic TherapeuticN/AN/A$12.16M-$5.89-6.04

Tectonic Therapeutic's return on equity of -35.53% beat Kyverna Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Kyverna TherapeuticsN/A -51.12% -37.91%
Tectonic Therapeutic N/A -35.53%-31.97%

Summary

Tectonic Therapeutic beats Kyverna Therapeutics on 8 of the 13 factors compared between the two stocks.

Get Kyverna Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KYTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KYTX vs. The Competition

MetricKyverna TherapeuticsBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$130.81M$3.09B$5.76B$9.21B
Dividend YieldN/A1.67%5.27%3.99%
P/E RatioN/A45.4825.2619.41
Price / Sales18.61297.96466.7676.15
Price / CashN/A192.7646.0638.90
Price / BookN/A4.057.325.05
Net Income-$60.37M-$40.60M$3.19B$222.81M
7 Day Performance0.66%3.50%1.68%1.29%
1 Month Performance-9.01%4.18%4.11%1.52%
1 Year Performance-89.73%-10.55%22.10%16.53%

Kyverna Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KYTX
Kyverna Therapeutics
1.9208 of 5 stars
$3.03
-0.3%
$25.71
+748.7%
-89.7%$130.81M$7.03M0.0096
TECX
Tectonic Therapeutic
3.042 of 5 stars
$34.77
-4.6%
$80.50
+131.5%
N/A$512.86MN/A-5.90120Gap Up
AUTL
Autolus Therapeutics
2.6657 of 5 stars
$1.92
-5.4%
$10.40
+441.7%
-70.1%$510.89M$1.70M-1.59330Short Interest ↑
Negative News
TKNO
Alpha Teknova
0.9432 of 5 stars
$9.17
+1.8%
$8.50
-7.3%
+162.0%$488.85M$36.68M-12.39240News Coverage
SNDL
SNDL
3.6182 of 5 stars
$1.85
-0.5%
$3.25
+75.7%
+24.8%$486.14M$673.33M-5.972,516
TRDA
Entrada Therapeutics
2.7329 of 5 stars
$12.86
-0.6%
$25.67
+99.6%
-6.5%$481.22M$129.01M8.09110
KMDA
Kamada
4.4297 of 5 stars
$8.33
+8.3%
$14.50
+74.1%
+26.9%$478.81M$142.52M29.75360Positive News
Gap Up
High Trading Volume
MLYS
Mineralys Therapeutics
3.1 of 5 stars
$9.51
-3.1%
$30.00
+215.5%
-33.9%$473.31MN/A-2.9128Earnings Report
RNAC
Cartesian Therapeutics
2.6191 of 5 stars
$18.51
+0.8%
$42.86
+131.5%
-16.7%$470.43M$47.94M-0.3564
ALT
Altimmune
2.7909 of 5 stars
$6.61
-0.8%
$20.83
+215.2%
-27.3%$470.10M$430,000.00-4.2650Short Interest ↓
MREO
Mereo BioPharma Group
2.83 of 5 stars
$3.02
-2.9%
$7.83
+159.4%
-22.6%$468.55M$10M0.0040Gap Up

Related Companies and Tools


This page (NASDAQ:KYTX) was last updated on 2/17/2025 by MarketBeat.com Staff
From Our Partners